Mixed phenotype acute leukemia: 13 patients and a proposed management algorithm

Leukemia Research Reports · Published 2026-08-01 · DOI 10.1016/j.lrr.2026.100602

Free full text

Authors (6)

Wafa Chenbah, Mohamed Ben Abdelkrim, Manel Kasdallah, Nadia Sassi, Monia Guermazi, Yosra Ben Youssef

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chenbah, W., Abdelkrim, M., Kasdallah, M., et al. (2026). Mixed phenotype acute leukemia: 13 patients and a proposed management algorithm. Leukemia Research Reports. https://doi.org/10.1016/j.lrr.2026.100602

Related articles

• Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma · Leukemia Research Reports · 2026 · Same journal
• Mechanisms and signaling pathways of tyrosine kinase inhibitor resistance in chronic myeloid leukemia: A comprehensive review · Leukemia Research Reports · 2025 · Same journal
• Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm · Leukemia Research Reports · 2025 · Same journal
• Fatal case of disseminated toxoplasmosis following allogeneic stem cell transplantation in Singapore – a case report and review of literature · Leukemia Research Reports · 2025 · Same journal
• JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights · Leukemia Research Reports · 2026 · Same journal
• Leukocytosis and a JAK2 mutation: The importance of expertise in somatic variant interpretation · Leukemia Research Reports · 2026 · Same journal
• Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An Indian experience · Leukemia Research Reports · 2025 · Same journal
• Synchronous presentation of pH+ B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia treated with blinatumomab · Leukemia Research Reports · 2026 · Same journal
• Synergistic effects of luspatercept and cyclosporine A in lower-risk myelodysplastic syndrome with red cell aplasia: Two case insights · Leukemia Research Reports · 2026 · Same journal
• Systemic, asymptomatic skeletal muscle infiltration by MALT lymphoma: Defining a 'silent infiltrator' phenotype with 18F-FDG PET/CT · Leukemia Research Reports · 2026 · Same journal